KXD1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	13 studies	22% ± 5%	Explore
fibroblast	12 studies	23% ± 11%	Explore
regulatory T cell	12 studies	23% ± 5%	Explore
non-classical monocyte	11 studies	25% ± 10%	Explore
B cell	11 studies	19% ± 4%	Explore
CD8-positive, alpha-beta T cell	11 studies	26% ± 6%	Explore
CD4-positive, alpha-beta T cell	10 studies	25% ± 7%	Explore
classical monocyte	10 studies	24% ± 8%	Explore
endothelial cell	10 studies	26% ± 11%	Explore
gamma-delta T cell	10 studies	21% ± 10%	Explore
macrophage	9 studies	21% ± 5%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	20% ± 3%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	20% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	20% ± 4%	Explore
CD8-positive, alpha-beta memory T cell	7 studies	20% ± 5%	Explore
conventional dendritic cell	7 studies	29% ± 15%	Explore
mucosal invariant T cell	7 studies	19% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	22% ± 4%	Explore
mature NK T cell	6 studies	18% ± 2%	Explore
smooth muscle cell	6 studies	21% ± 5%	Explore
epithelial cell	6 studies	34% ± 14%	Explore
naive B cell	6 studies	17% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	22% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	19% ± 2%	Explore
pericyte	5 studies	21% ± 5%	Explore
connective tissue cell	5 studies	21% ± 5%	Explore
memory B cell	5 studies	20% ± 4%	Explore
plasmacytoid dendritic cell	5 studies	21% ± 5%	Explore
T cell	5 studies	21% ± 4%	Explore
hematopoietic precursor cell	4 studies	26% ± 9%	Explore
plasma cell	4 studies	28% ± 10%	Explore
myofibroblast cell	4 studies	20% ± 1%	Explore
myeloid cell	4 studies	23% ± 6%	Explore
ciliated cell	4 studies	31% ± 7%	Explore
T follicular helper cell	4 studies	19% ± 2%	Explore
abnormal cell	4 studies	27% ± 10%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	26% ± 4%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	30% ± 7%	Explore
endothelial cell of vascular tree	4 studies	18% ± 2%	Explore
dendritic cell	4 studies	35% ± 15%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	23% ± 5%	Explore
basal cell	4 studies	31% ± 14%	Explore
plasmablast	3 studies	50% ± 9%	Explore
pancreatic A cell	3 studies	29% ± 5%	Explore
endothelial cell of lymphatic vessel	3 studies	25% ± 6%	Explore
precursor B cell	3 studies	17% ± 1%	Explore
monocyte	3 studies	21% ± 4%	Explore
erythroblast	3 studies	30% ± 16%	Explore
exhausted T cell	3 studies	23% ± 5%	Explore
intermediate monocyte	3 studies	30% ± 13%	Explore
goblet cell	3 studies	22% ± 5%	Explore
double negative thymocyte	3 studies	28% ± 10%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	11 studies	21% ± 5%	Explore
lung	6 studies	25% ± 8%	Explore
pancreas	3 studies	28% ± 1%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
bladder	100%	3456.43	21 / 21	100%	27.37	504 / 504
esophagus	100%	3157.29	1445 / 1445	100%	25.78	183 / 183
intestine	100%	3142.63	966 / 966	100%	28.93	527 / 527
liver	100%	1985.06	226 / 226	100%	17.37	406 / 406
ovary	100%	3212.77	180 / 180	100%	37.45	430 / 430
pancreas	100%	2069.05	328 / 328	100%	24.30	178 / 178
prostate	100%	3566.14	245 / 245	100%	24.90	502 / 502
skin	100%	3021.24	1809 / 1809	100%	29.60	472 / 472
stomach	100%	2462.68	359 / 359	100%	28.37	286 / 286
uterus	100%	3140.06	170 / 170	100%	26.13	459 / 459
brain	100%	2245.53	2640 / 2642	100%	32.83	705 / 705
lung	100%	3265.59	578 / 578	100%	25.20	1154 / 1155
breast	100%	3345.70	459 / 459	100%	23.94	1117 / 1118
kidney	100%	2497.24	89 / 89	100%	21.64	900 / 901
thymus	100%	3093.78	653 / 653	100%	25.11	603 / 605
adrenal gland	100%	2833.58	258 / 258	99%	20.20	227 / 230
adipose	100%	3304.33	1204 / 1204	0%	0	0 / 0
blood vessel	100%	3775.25	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	21.20	80 / 80
lymph node	0%	0	0 / 0	100%	30.03	29 / 29
muscle	100%	2174.12	803 / 803	0%	0	0 / 0
spleen	100%	3589.31	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	23.59	45 / 45
ureter	0%	0	0 / 0	100%	15.81	1 / 1
heart	100%	2004.39	857 / 861	0%	0	0 / 0
peripheral blood	99%	2829.02	920 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0072384	Biological process	organelle transport along microtubule
GO_0051036	Biological process	regulation of endosome size
GO_0016192	Biological process	vesicle-mediated transport
GO_0032418	Biological process	lysosome localization
GO_0062196	Biological process	regulation of lysosome size
GO_0098574	Cellular component	cytoplasmic side of lysosomal membrane
GO_0099078	Cellular component	BORC complex
GO_0031083	Cellular component	BLOC-1 complex
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	KXD1
Protein name	KxDL motif-containing protein 1
Synonyms	C19orf50
Description	FUNCTION: As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor . May be involved in the biogenesis of lysosome-related organelles such as melanosomes (By similarity). .
Accessions	ENST00000597438.5 ENST00000601630.5 ENST00000222307.9 ENST00000595073.5 M0QY77 ENST00000600372.5 Q9BQD3 M0QXP3 ENST00000598830.5 ENST00000600099.1 ENST00000539106.5 ENST00000600654.5 ENST00000599000.5 ENST00000602094.5 ENST00000540691.5 ENST00000596785.5 ENST00000595870.5 ENST00000599319.5 M0QX74 M0R228 M0R2G3 M0R0B4 M0QXN9

KXD1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review